FILE PHOTO: A nurse prepares Russia's "Sputnik-V" vaccine against the coronavirus disease (COVID-19) for inoculation in a post-registration trials stage at a clinic in Moscow, Russia September 17, 2020. REUTERS/Tatyana Makeyeva/File Photo
MOSCOW (Reuters) - Russia's sovereign wealth fund said on Tuesday it had agreed to supply 25 million doses of its potential COVID-19 vaccine to Nepal via Trinity Pharmaceuticals, which it described as a private healthcare firm and key distributor there.
The Russian Direct Investment Fund has struck multiple Sputnik V vaccine supply deals abroad, including to supply 100 million doses to India, where it also expects to hold clinical trials.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
